Accounting for Hormonal Factors in Traumatic Brain Injury Care for Women: Christine Greiss, DO
May 7th 2025The medical director for the Center for Brain injuries at Hackensack Meridian Health provided recommendations for clinicians to consider in the rehabilitation of women with TBI. [WATCH TIME: 6 minutes]
Eric Baron, DO, on the Approval of CT-132: A Digital Shift in Migraine Care
May 6th 2025Baron, a neurologist and headache specialist at Cleveland Clinic, explained the significance, clinical data, and patient potential behind CT-132, the first FDA-approved digital therapeutic for migraine prevention.
Patient Insights and Evolving Treatment Combos in PD
May 5th 2025Pagan discussed unexpected findings from the InfusON study patient interviews that could influence how neurologists introduce CSAI therapy and how these insights, along with the latest data on MAO-B inhibitors, could shape future treatment combinations for Parkinson disease.
Gene-Targeted Therapies and Biomarkers Driving ALS Research Forward: Brian Lin, PhD
May 4th 2025The research portfolio director at the Muscular Dystrophy Association talked about recent advances in ALS research highlight the promise of gene-targeted treatments and the increasing utility of biomarkers for diagnosis. [WATCH TIME: 3 minutes]
Hormonal and Neurological Complexity in Traumatic Brain Injury Recovery for Women
May 4th 2025Christine Greiss, DO, medical director for the Center for Brain injuries at Hackensack Meridian Health, discussed the nuanced impact of hormonal fluctuations, psychological factors, and postmenopausal status on TBI recovery in women.
Technological Advances Leading the Future of Parkinson Care: Cheryl Kyinn, PA-C
May 3rd 2025A physician assistant specializing in Parkinson disease talked about how emerging technologies and proactive care models could transform the treatment landscape for Parkinson disease. [WATCH TIME: 4 minutes]